Vaccination in multiple sclerosis ‑ Challenging practices (Review)
Infections are an ever-present problem in the medical community, even more so for patients with multiple sclerosis (MS), for whom these infections have been linked to relapses and neurological disabilities. Even though it was believed that MS can be caused by an infection, research does not support...
Gespeichert in:
| Veröffentlicht in: | Experimental and therapeutic medicine 2020-12, Vol.20 (6), p.1-1 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1 |
|---|---|
| container_issue | 6 |
| container_start_page | 1 |
| container_title | Experimental and therapeutic medicine |
| container_volume | 20 |
| creator | Sirbu, Carmen Adella Florea, Anca Alexandra Ghinescu, Minerva Claudia Docu-Axelerad, Any Sirbu, Anca Maria Bratu, Ovidiu Gabriel Radu, Florentina Ionita |
| description | Infections are an ever-present problem in the medical community, even more so for patients with multiple sclerosis (MS), for whom these infections have been linked to relapses and neurological disabilities. Even though it was believed that MS can be caused by an infection, research does not support this theory. MS is a chronic inflammatory disease considered to be autoimmune. Vaccination is proven to be one of the most effective means to prevent infections, but still it is surrounded by controversy in the general populations, as well as in the MS group. Vaccines are generally considered safe for MS patients. The exceptions from this, which turn into contraindications, are a medical history of allergic reactions to one of the vaccine components and immunosuppressed patients in the particular case of live vaccines. Given the presumed autoimmunity of the disease, some medication for MS is immunosuppressive and any live vaccine should be administered before starting treatment. Although there is still confusion regarding this subject, the current guidelines have clearer recommendations about vaccinations in MS patients and especially in treated MS patients. |
| doi_str_mv | 10.3892/etm.2020.9347 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7604740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A646884981</galeid><sourcerecordid>A646884981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-928bad0a41debb23184af2778bf20d9f604ce83cfd54003cc196c6caa2ab1ebb3</originalsourceid><addsrcrecordid>eNptkc9qFTEUxoMottQu3Q900y7mNv9mkmwK5apVKAiibkPmzJnblExyO5mpuPMVfEWfpLn0YqmYLHJIvu9LTn6EvGV0JbTh5ziPK045XRkh1QtyyJThNaOsebmvqdHsgBznfEvLaFqmdfOaHAjBpFGaHZJ33x2Aj272KVY-VuMSZr8NWGUIOKXsc_Xn1-9qfeNCwLjxcVNtJwezB8zV6Re89_jj7A15NbiQ8Xi_HpFvH95_XX-srz9ffVpfXtdQXjvXhuvO9dRJ1mPXccG0dANXSncDp70ZWioBtYChbySlAoCZFlpwjruOFYc4IhePudulG7EHjPPkgt1OfnTTT5uct89Por-xm3RvVYlWkpaA033AlO4WzLMdfQYMwUVMS7ZcNsq0SsimSE_-kd6mZYqlvaJqRflL1agn1cYFtD4OqdwLu1B72cpWa1kAFNXqP6oyexw9pIiDL_vPDPWjAQqCPOHwt0dG7Y68LeTtjrzdkRcPmjifzA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2463056757</pqid></control><display><type>article</type><title>Vaccination in multiple sclerosis ‑ Challenging practices (Review)</title><source>PubMed Central</source><creator>Sirbu, Carmen Adella ; Florea, Anca Alexandra ; Ghinescu, Minerva Claudia ; Docu-Axelerad, Any ; Sirbu, Anca Maria ; Bratu, Ovidiu Gabriel ; Radu, Florentina Ionita</creator><creatorcontrib>Sirbu, Carmen Adella ; Florea, Anca Alexandra ; Ghinescu, Minerva Claudia ; Docu-Axelerad, Any ; Sirbu, Anca Maria ; Bratu, Ovidiu Gabriel ; Radu, Florentina Ionita</creatorcontrib><description>Infections are an ever-present problem in the medical community, even more so for patients with multiple sclerosis (MS), for whom these infections have been linked to relapses and neurological disabilities. Even though it was believed that MS can be caused by an infection, research does not support this theory. MS is a chronic inflammatory disease considered to be autoimmune. Vaccination is proven to be one of the most effective means to prevent infections, but still it is surrounded by controversy in the general populations, as well as in the MS group. Vaccines are generally considered safe for MS patients. The exceptions from this, which turn into contraindications, are a medical history of allergic reactions to one of the vaccine components and immunosuppressed patients in the particular case of live vaccines. Given the presumed autoimmunity of the disease, some medication for MS is immunosuppressive and any live vaccine should be administered before starting treatment. Although there is still confusion regarding this subject, the current guidelines have clearer recommendations about vaccinations in MS patients and especially in treated MS patients.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2020.9347</identifier><identifier>PMID: 33149781</identifier><language>eng</language><publisher>Athens: Spandidos Publications</publisher><subject>Aluminum ; Antibodies ; Antigens ; Autoimmune diseases ; Care and treatment ; Disease ; Genetic engineering ; Hepatitis B ; Human papillomavirus ; Immune system ; Infection ; Infections ; Influenza ; Lymphocytes ; Measles ; Methods ; Multiple sclerosis ; Mumps ; Pathogens ; Poliomyelitis ; Prevention ; Proteins ; Review ; Rubella ; Tetanus ; Tropical diseases ; Typhoid ; Vaccination ; Vaccines ; Whooping cough</subject><ispartof>Experimental and therapeutic medicine, 2020-12, Vol.20 (6), p.1-1</ispartof><rights>COPYRIGHT 2020 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2020</rights><rights>Copyright © 2020, Spandidos Publications 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-928bad0a41debb23184af2778bf20d9f604ce83cfd54003cc196c6caa2ab1ebb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604740/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604740/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids></links><search><creatorcontrib>Sirbu, Carmen Adella</creatorcontrib><creatorcontrib>Florea, Anca Alexandra</creatorcontrib><creatorcontrib>Ghinescu, Minerva Claudia</creatorcontrib><creatorcontrib>Docu-Axelerad, Any</creatorcontrib><creatorcontrib>Sirbu, Anca Maria</creatorcontrib><creatorcontrib>Bratu, Ovidiu Gabriel</creatorcontrib><creatorcontrib>Radu, Florentina Ionita</creatorcontrib><title>Vaccination in multiple sclerosis ‑ Challenging practices (Review)</title><title>Experimental and therapeutic medicine</title><description>Infections are an ever-present problem in the medical community, even more so for patients with multiple sclerosis (MS), for whom these infections have been linked to relapses and neurological disabilities. Even though it was believed that MS can be caused by an infection, research does not support this theory. MS is a chronic inflammatory disease considered to be autoimmune. Vaccination is proven to be one of the most effective means to prevent infections, but still it is surrounded by controversy in the general populations, as well as in the MS group. Vaccines are generally considered safe for MS patients. The exceptions from this, which turn into contraindications, are a medical history of allergic reactions to one of the vaccine components and immunosuppressed patients in the particular case of live vaccines. Given the presumed autoimmunity of the disease, some medication for MS is immunosuppressive and any live vaccine should be administered before starting treatment. Although there is still confusion regarding this subject, the current guidelines have clearer recommendations about vaccinations in MS patients and especially in treated MS patients.</description><subject>Aluminum</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Autoimmune diseases</subject><subject>Care and treatment</subject><subject>Disease</subject><subject>Genetic engineering</subject><subject>Hepatitis B</subject><subject>Human papillomavirus</subject><subject>Immune system</subject><subject>Infection</subject><subject>Infections</subject><subject>Influenza</subject><subject>Lymphocytes</subject><subject>Measles</subject><subject>Methods</subject><subject>Multiple sclerosis</subject><subject>Mumps</subject><subject>Pathogens</subject><subject>Poliomyelitis</subject><subject>Prevention</subject><subject>Proteins</subject><subject>Review</subject><subject>Rubella</subject><subject>Tetanus</subject><subject>Tropical diseases</subject><subject>Typhoid</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Whooping cough</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkc9qFTEUxoMottQu3Q900y7mNv9mkmwK5apVKAiibkPmzJnblExyO5mpuPMVfEWfpLn0YqmYLHJIvu9LTn6EvGV0JbTh5ziPK045XRkh1QtyyJThNaOsebmvqdHsgBznfEvLaFqmdfOaHAjBpFGaHZJ33x2Aj272KVY-VuMSZr8NWGUIOKXsc_Xn1-9qfeNCwLjxcVNtJwezB8zV6Re89_jj7A15NbiQ8Xi_HpFvH95_XX-srz9ffVpfXtdQXjvXhuvO9dRJ1mPXccG0dANXSncDp70ZWioBtYChbySlAoCZFlpwjruOFYc4IhePudulG7EHjPPkgt1OfnTTT5uct89Por-xm3RvVYlWkpaA033AlO4WzLMdfQYMwUVMS7ZcNsq0SsimSE_-kd6mZYqlvaJqRflL1agn1cYFtD4OqdwLu1B72cpWa1kAFNXqP6oyexw9pIiDL_vPDPWjAQqCPOHwt0dG7Y68LeTtjrzdkRcPmjifzA</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Sirbu, Carmen Adella</creator><creator>Florea, Anca Alexandra</creator><creator>Ghinescu, Minerva Claudia</creator><creator>Docu-Axelerad, Any</creator><creator>Sirbu, Anca Maria</creator><creator>Bratu, Ovidiu Gabriel</creator><creator>Radu, Florentina Ionita</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201201</creationdate><title>Vaccination in multiple sclerosis ‑ Challenging practices (Review)</title><author>Sirbu, Carmen Adella ; Florea, Anca Alexandra ; Ghinescu, Minerva Claudia ; Docu-Axelerad, Any ; Sirbu, Anca Maria ; Bratu, Ovidiu Gabriel ; Radu, Florentina Ionita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-928bad0a41debb23184af2778bf20d9f604ce83cfd54003cc196c6caa2ab1ebb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aluminum</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Autoimmune diseases</topic><topic>Care and treatment</topic><topic>Disease</topic><topic>Genetic engineering</topic><topic>Hepatitis B</topic><topic>Human papillomavirus</topic><topic>Immune system</topic><topic>Infection</topic><topic>Infections</topic><topic>Influenza</topic><topic>Lymphocytes</topic><topic>Measles</topic><topic>Methods</topic><topic>Multiple sclerosis</topic><topic>Mumps</topic><topic>Pathogens</topic><topic>Poliomyelitis</topic><topic>Prevention</topic><topic>Proteins</topic><topic>Review</topic><topic>Rubella</topic><topic>Tetanus</topic><topic>Tropical diseases</topic><topic>Typhoid</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Whooping cough</topic><toplevel>online_resources</toplevel><creatorcontrib>Sirbu, Carmen Adella</creatorcontrib><creatorcontrib>Florea, Anca Alexandra</creatorcontrib><creatorcontrib>Ghinescu, Minerva Claudia</creatorcontrib><creatorcontrib>Docu-Axelerad, Any</creatorcontrib><creatorcontrib>Sirbu, Anca Maria</creatorcontrib><creatorcontrib>Bratu, Ovidiu Gabriel</creatorcontrib><creatorcontrib>Radu, Florentina Ionita</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sirbu, Carmen Adella</au><au>Florea, Anca Alexandra</au><au>Ghinescu, Minerva Claudia</au><au>Docu-Axelerad, Any</au><au>Sirbu, Anca Maria</au><au>Bratu, Ovidiu Gabriel</au><au>Radu, Florentina Ionita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccination in multiple sclerosis ‑ Challenging practices (Review)</atitle><jtitle>Experimental and therapeutic medicine</jtitle><date>2020-12-01</date><risdate>2020</risdate><volume>20</volume><issue>6</issue><spage>1</spage><epage>1</epage><pages>1-1</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>Infections are an ever-present problem in the medical community, even more so for patients with multiple sclerosis (MS), for whom these infections have been linked to relapses and neurological disabilities. Even though it was believed that MS can be caused by an infection, research does not support this theory. MS is a chronic inflammatory disease considered to be autoimmune. Vaccination is proven to be one of the most effective means to prevent infections, but still it is surrounded by controversy in the general populations, as well as in the MS group. Vaccines are generally considered safe for MS patients. The exceptions from this, which turn into contraindications, are a medical history of allergic reactions to one of the vaccine components and immunosuppressed patients in the particular case of live vaccines. Given the presumed autoimmunity of the disease, some medication for MS is immunosuppressive and any live vaccine should be administered before starting treatment. Although there is still confusion regarding this subject, the current guidelines have clearer recommendations about vaccinations in MS patients and especially in treated MS patients.</abstract><cop>Athens</cop><pub>Spandidos Publications</pub><pmid>33149781</pmid><doi>10.3892/etm.2020.9347</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1792-0981 |
| ispartof | Experimental and therapeutic medicine, 2020-12, Vol.20 (6), p.1-1 |
| issn | 1792-0981 1792-1015 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7604740 |
| source | PubMed Central |
| subjects | Aluminum Antibodies Antigens Autoimmune diseases Care and treatment Disease Genetic engineering Hepatitis B Human papillomavirus Immune system Infection Infections Influenza Lymphocytes Measles Methods Multiple sclerosis Mumps Pathogens Poliomyelitis Prevention Proteins Review Rubella Tetanus Tropical diseases Typhoid Vaccination Vaccines Whooping cough |
| title | Vaccination in multiple sclerosis ‑ Challenging practices (Review) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T03%3A07%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccination%20in%20multiple%20sclerosis%20%E2%80%91%20Challenging%20practices%20(Review)&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Sirbu,%20Carmen%20Adella&rft.date=2020-12-01&rft.volume=20&rft.issue=6&rft.spage=1&rft.epage=1&rft.pages=1-1&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2020.9347&rft_dat=%3Cgale_pubme%3EA646884981%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2463056757&rft_id=info:pmid/33149781&rft_galeid=A646884981&rfr_iscdi=true |